APA (7th ed.) Citation

S, S., EE, T., CS, T., TJ, H., SM, O., & RB, D. (2018). Dose modification for safe treatment of a compound complex heterozygous DPYD variant carrier with 5-fluorouracil. JCO precision oncology, 2, . https://doi.org/10.1200/po.18.00179

Chicago Style (17th ed.) Citation

S, Shrestha, Tapper EE, Trogstad-Isaacson CS, Hobday TJ, Offer SM, and Diasio RB. "Dose Modification for Safe Treatment of a Compound Complex Heterozygous DPYD Variant Carrier with 5-fluorouracil." JCO Precision Oncology 2 (2018). https://doi.org/10.1200/po.18.00179.

MLA (9th ed.) Citation

S, Shrestha, et al. "Dose Modification for Safe Treatment of a Compound Complex Heterozygous DPYD Variant Carrier with 5-fluorouracil." JCO Precision Oncology, vol. 2, 2018, https://doi.org/10.1200/po.18.00179.